• Vicplas International reported a wider annual loss for the year ended July 31, 2026, as medical device operating costs increased.
• The Mexico plant began generating revenue from initial production, but project delays weighed on the medical devices segment.
• Pipes and pipe fittings delivered stronger earnings, supported by robust Singapore construction demand and higher Malaysian sales.
• No annual dividend was recommended following the loss.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Vicplas International Ltd. published the original content used to generate this news brief via Singapore Exchange Limited (SGX) (Ref. ID: FKROLWFT6M91MNK8) on November 10, 2026, and is solely responsible for the information contained therein.